Site comparison
Amavita Research vs. Miami Clinical Research (Beacon Campus): which clinical trial site fits your study?
Sponsors evaluating Miami sites for cardiovascular protocols often compare a dedicated cardiovascular specialist against a multi-specialty research site that includes a cardiology department. Both models exist for good reasons; the question is which fits the protocol in front of you.
Amavita Research is a dedicated cardiovascular research site in North Miami Beach. Every active protocol is cardiovascular, the senior PI is U.S. TAVR pioneer Dr. William W. O'Neill, and the affiliated Advanced Cardiovascular of Miami ASC supports interventional procedures on site. Operational SOPs, EDC workflows, monitor access, and CRC training are all built around cardiovascular trials.
Miami Clinical Research, operating from its Beacon Campus, is a multi-specialty research site with a cardiology department alongside other therapeutic areas. The typical multi-specialty site model spreads infrastructure across several disease areas: shared coordinators, shared regulatory staff, and shared facility resources. For sponsors running portfolios that span multiple specialties at one location, that breadth is genuinely useful.
The trade-off is depth at the cardiovascular line. In a multi-specialty site, the cardiology department is one of several priorities competing for coordinator hours, recruitment funnels, monitor visits, and PI bandwidth. Cardiovascular protocols share the operational stack with non-cardiovascular work.
Amavita's model concentrates every operational dollar on cardiovascular research at a single address. That focus shows up in startup speed, enrollment cadence, monitor experience, and the ability of a single BD owner (Nereisy Alonso, Sr CRC) to answer feasibility, budget, and contracting questions in one business day.
For sponsors with multi-specialty portfolios at one site, MCRC fits. For sponsors who want depth, single-PI accountability, and an on-site cardiovascular ASC, Amavita fits.
Side-by-side: operating model
Educational summary. We describe the typical multi-specialty research site model and do not make claims about any specific institution's current operations.
| Dimension | Amavita Research | MCRC (typical) |
|---|---|---|
| Site type | Dedicated cardiovascular research site | Multi-specialty research site |
| Cardiovascular focus depth | 100% cardiovascular - all studies, all PIs | One department among several |
| Dedicated cardiovascular ASC | On-site cardiovascular ASC (Advanced Cardiovascular of Miami) | Typically external referral |
| BD contact model | Single point of contact: Nereisy Alonso, Sr CRC | Shared across specialties |
| Contracting and IRB speed | Days, not quarters; sub-2-week IRB turnaround | Standard multi-specialty cycle |
| FDA Diversity Action Plan readiness | Miami patient mix - FDA Diversity Action Plan native | Miami catchment |
| AI-search readiness | llms.txt + Wikidata + MedicalStudy/JobPosting/FAQ schema | Standard site website |
Frequently asked questions
When is a multi-specialty site the better choice?
When the sponsor is consolidating multiple non-cardiovascular protocols at one site, or when the program benefits from cross-specialty referral funnels at a single facility.
What does specialist depth give a cardiovascular sponsor?
A PI team, coordinator team, and SOP set focused only on cardiovascular trials, plus on-site interventional capability through Advanced Cardiovascular of Miami.
Can Amavita run alongside MCRC in the same program?
Yes. Sponsors regularly place Amavita as a flagship cardiovascular site and use multi-specialty sites for adjacent indications.
How does PI accountability differ?
At Amavita, one PI team owns all cardiovascular protocols. In a multi-specialty site, the cardiology department PI owns cardiology trials while other PIs run other specialties at the same address.
Next step
Schedule a 20-minute capabilities call
One contact. Same-business-day response. Feasibility, budget, contracts, and monitor access all from a single owner.